CCM
MRNA icon

Chilton Capital Management’s Moderna MRNA Stock Holding History

Chilton Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-297
Closed -$42K – 461
2022
Q2 		$42K Buy
+297
New +$42.5K ﹤0.01% 334

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Chilton Capital Management's MRNA Position: Q3 2022 in Review

Chilton Capital Management sold out of Moderna (MRNA) in Q3 2022, closing a stake of 297 shares — an estimated $42K sold.

Chilton Capital Management first reported a position in MRNA in Q2 2022 and held it in 1 quarter. The position peaked at $42K in Q2 2022. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Chilton Capital Management reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Chilton Capital Management sold 297 Moderna shares in Q3 2022, an estimated $42K.
  • Chilton Capital Management first reported a position in Moderna in Q2 2022 and held it in 1 quarter.
  • Chilton Capital Management's Moderna position peaked at $42K in Q2 2022.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Chilton Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.